N.J. Judge Recommends Adding Generic Cases to Accutane Mass Tort

ATLANTIC CITY, N.J. - The New Jersey state judge overseeing the Accutane mass tort program has recommended that litigation involving the drug's generic version, isotretinoin, be designated as part of the Accutane litigation. In re: Accutane Litigation, No. MDL 271 (N.J. Super. Ct., Atlantic Cty.).

In a March 14 proposal, Atlantic County Superior Court Judge Carol E. Higbee explained that over the past several years an increased number of cases involving isotretinoin have been filed in Atlantic County. The defendant manufacturers are Mylan Bertek Pharmaceuticals, Ranbaxy Pharmaceuticals Inc., Ranbaxy Laboratories Inc., Barr Pharmaceuticals LLC, Barr Laboratories Inc., Cardinal Health 409 …